Latest News
Initial study results of an innovative glaucoma therapy involving eye implants have yielded positive results, and a Phase 2 clinical trial of this exciting potential treatment has begun.
BrightFocus-funded research offers the potential to restore vision loss due to glaucoma using cell replacement therapy.
January is National Glaucoma Awareness Month, and BrightFocus Foundation is offering a variety of free educational resources to help individuals with glaucoma and their loved ones navigate the disease.
A team of BrightFocus-funded scientists has proposed a new explanation and possible new target for treatment in glaucoma that’s unrelated to the common culprit of eye pressure.
In this issue:
- Glaucoma and Corneal Thickness
- President’s Corner
- Identifying New Risk Factors and Treatments for Glaucoma
- And more!
The newly expanded accessible audio program will connect patients with vision experts and provide the latest glaucoma research news.
Jason Meyer, PhD, is a BrightFocus Foundation success story and a pioneer in the effort to regenerate eye tissue that is damaged by glaucoma.
In this issue:
- New Ways to Diagnose and Monitor Glaucoma
- President's Corner
- Gene for Repairing Retinal Cells Identified
- And More!
In this Issue:
- Scientists Discover Key Gene Associated with Glaucoma
- President's Corner
- The Importance of Your Eye's Drainage System
- Spotlight On... Dr. Puya Gharahkhani, PhD
- And More!
BrightFocus Foundation, a leading nonprofit funder of vision research, has announced a request for proposals for scientific projects supported through its National Glaucoma Research (NGR) program. The application deadline is October 25, 2022, for projects beginning in 2023.
